Growth hormone therapy does not induce cancer
- 1 October 2006
- journal article
- review article
- Published by Springer Nature in Nature Clinical Practice Endocrinology & Metabolism
- Vol. 2 (10), 532-533
- https://doi.org/10.1038/ncpendmet0294
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Adult growth hormone replacement therapy and neuroimaging surveillance in brain tumour survivorsClinical Endocrinology, 2005
- Growth Hormone and Pituitary Radiotherapy, But Not Serum Insulin-Like Growth Factor-I Concentrations, Predict Excess Mortality in Patients with AcromegalyJournal of Clinical Endocrinology & Metabolism, 2004
- Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysisThe Lancet, 2004
- Long-term experience with GH replacement therapy: efficacy and safetyActa Endocrinologica, 2003
- Outcomes of Growth Hormone Replacement Therapy in Survivors of Childhood Acute Lymphoblastic LeukemiaJournal of Clinical Oncology, 2002
- Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959–85: a cohort studyThe Lancet, 2002
- Risk of Disease Recurrence and Second Neoplasms in Survivors of Childhood Cancer Treated with Growth Hormone: A Report from the Childhood Cancer Survivor StudyJournal of Clinical Endocrinology & Metabolism, 2002
- CLINICAL PERSPECTIVE: Acromegaly and Cancer: Not a Problem?Journal of Clinical Endocrinology & Metabolism, 2001